Диссертация (1141219), страница 23
Текст из файла (страница 23)
// Clin Res Cardiol. – 2018 – №2 – Р.130-137.63.Elliot P., Anderson B., Arbustini E., et al. Classification of the cardiomyopathies: aposition statement from the European Society of Cardiology Working Group onMyocardial and pericardial diseases. // Eur. Heart J – 2008 – № 29 – Р.
270-276.64.Elliot P., Gimeno J.R. Left ventricular outflow tract obstruction and SCD risk inpatients with HCM. // Eur. Heart J – 2016 – № 27 – Р.193-1941.15065.Emery MS, Kovacs RJ. Sudden Cardiac Death in Athletes. // JACC Heart Fail. –2018 – № 6(1) – Р. 30-40.66.Ertaş F, Yavuz C, Kaya H, et al. The relationship between QT dispersion andexaggerated blood pressure response to exercise stress testing. // Clin ExpHypertens. – 2013 – №35(6) – Р.470-4.67.ESH-ESC Guidelines Committee. ESH-ESC guidelines for management of arterialhypertension. // J. Hypertens. – 2007 - Vol.
25 – P. 1005-1087.68.Eshraghi A, Ebdali RT, Sajjadi SS, et al. Diagnostic value of electrocardiogram inpredicting exaggerated blood pressure response to exercise stress testing. electronphysician. – 2016 – №25;8(8) – Р.2765-2771.69.Finocchiare G., Papadakis M., Robertus J., et al. Etiology of sudden death in sports:insight from a United Kingdom Regional Registry //Journal of the AmericanCollege of Cardiology. – 2016 – Vol.
67 – № 18 – P. 2108-2115.70.Foley RN, Curtis BM, Randell EW, et al. Left ventricular hypertrophy in newhemodialysis patients without symptomatic cardiac disease. // Clin J Am SocNephrol. – 2010 – №5 – Р.805-813.71.Forleo C, Carmosino M, Resta N, et al. Clinical and functional characterization ofa novel mutation in lamin a/c gene in a multigenerational family witharrhythmogenic cardiac laminopathy.
// PLoS One. – 2015 – №2 – Р.10(4).72.Gersh B.J., Maron B. 2011 ACCF/AHA guideline for the diagnosis and treatmentof hypertrophic cardiomyopathy: a report of the American College of CardiologyFoundation/American Heart Association Task Force on Practice Guidelines.
//JThorac Cardiovasc Surg. – 2011 – Vol.142 – №6 – Р.153-203.73.Gerch B.J., Maron B.J., Bonow R.O. et al. 2011 ACCF / AHA Guideline for theDiagnosis and treatment of HCM: a report of the American College of cardiologyFoundation/AHA Task force on Practice Guideline. // Circulation – 2011 – Vol.124– P.1304-1377.74.Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for thediagnosis and treatment of hypertrophic cardiomyopathy: executive summary: areport of the American College of Cardiology Foundation/American Heart151Association Task Force on Practice Guidelines. //J Am Coll Cardiol. – 2011 – Vol.58(25) – №13 – P.
2703-38.75.Grabysa R, Wańkowicz Z. Echocardiographic markers of left ventriculardysfunction among men with uncontrolled hypertension and stage 3 chronic kidneydisease. // Med Sci Monit. – 2013 – №9 – Vol.19 – P.838-45.76.Grazioli G, Usín D, Trucco E, et al. Differentiating hypertrophic cardiomyopathyfrom athlete's heart: An electrocardiographic and echocardiographic approach. // JElectrocardiol. – 2016 – №49 (4) – Р.539-44.77.Haarmark C, Hansen PR, Vedel-Larsen E, et al. The prognostic value of the T peakTend interval in patients undergoing primary percutaneous coronary interventionfor ST-segment elevation myocardial infarction. // J Electrocardiol.
– 2009 – Vol.42– №6 – Р.555–560.78.Hakim K, Boussaada R, Hamdi I, et al. Cardiac events in Costello syndrome: Onecase and a review of the literature. // J Saudi Heart Assoc. – 2014 – №26(2).79.Harmon K.G. Asif A.M., Maleszewski J., et al. Incidence and Etiology of SuddenCardiac Arrest and Death in High School Athletes in the United States. // MayoClin. Proc. – 2016 – №91– Vol.11– P.1493-1502.80.Hennein R, Hwang SJ, Au R, et al. Barriers to Medication Adherence and Links toCardiovascular Disease Risk Factor Control: The Framingham Heart Study. //Intern Med J. – 2017 – № 30.81.İmamoğluEY,EroğluAG.QT dispersion andventriculararrhythmiasin children with primary mitral valve prolapse.
// Turk Pediatri Ars. – 2016 – №1 –Vol. 51(3) – P.135-141.82.Irzmański R, Pawlicki L, Charłusz M., et al. Concentration of natriuretic peptidesin patients suffering from idiopathic arterial hypertension and left ventriculardiastolic dysfunction confirmed by echocardiography. // Clin Exp Hypertens.
–2012 – Vol.34 –№7 – Р. 530-4083.Janse MJ, Coronel R, Opthof T, et al. Repolarization gradients in the intact heart:transmural or apico-basal? // Prog Biophys Mol Biol. – 2012 – № 109(1-2) – Р. 615.15284.Khoury PR, Mitsnefes M, Daniels SR, et al. Age-specific reference intervals forindexed left ventricular mass in children. // J Am Soc Echocardiogr. – 2009 – №22– Р. 709-714.85.Kilić A, Bubikat A, Gassner B, et al. Local actions of atrial natriuretic peptidecounteract angiotensin II stimulated cardiac remodeling. // Endocrinology. – 2007– №148(9) – Р.4162-9.86.Koren M., Devereux R.
Relation of left ventricular mass and geometry to mobilityand mortality in uncomplicated essential hypertension. // Ann. Intern. Med. – 2008– №114 – P. 345-352.87.Kors JA, Ritsema van Eck HJ, van Herpen G., et al. The meaning of the Tp-Teinterval and its diagnostic value. // J Electrocardiol. – 2008 – №41(6) – Р.575-80.88.Lepechkin E, Surawich B. The measurement of the Q-T interval of theelectrocardiogram.
// Circulation – 1952 – №6 (3) – Р.378-88.89.Lutfullin IY, Kim ZF, Bilalova RR, et al. A 24-hour ambulatory ECG monitoringin assessment of QT interval duration and dispersion in rowers with physiologicalmyocardial hypertrophy. // Biol Sport. - 2013 - №30(4) – Р.237-41.90.Magnusson P, Gadler F, Liv P, et al. Risk Markers and Appropriate ImplantableDefibrillator Therapy in Hypertrophic Cardiomyopathy. // Pacing ClinElectrophysiol. – 2016 – №39(3) – Р.291-30.91.Magrì D, Piccirillo G, Ricotta A, et al.
Spatial QT Dispersion Predicts NonsustainedVentricular Tachycardia and Correlates with Confined Systo-diastolic Dysfunctionin Hypertrophic Cardiomyopathy. // Cardiology. – 2015 – №131(2) – Р.122-9.92.Maisel AS, Duran JM, Wettersten N, et al.Natriuretic Peptides in HeartFailure: Atrial and B-type Natriuretic Peptides. // Heart Fail Clin. – 2018 – №14(1)– Р.13-25.93.Maison-Blanche P., Coumel P. Changes in repolarization dynamicity and theassessment of the arrhythmic risk. // Pacing Clin Electrophysiol.
– 2007 – №20 –P.2614-24.15394.Mancia G., Facchetti R., Bombelli M. et al. Long-term risk of mortality associatedwith selective and combined elevation in office, home, and ambulatory bloodpressure. // Hypertension – 2016 – Vol. 47 – P. 846-853.95.Marijon E., Tafflet M., Celermajer D. et al. Sports-related sudden death in thegeneral population. // Circulation. – 2011 – Vol. 124 – P. 672-681.96.Maron B.J. Sudden death in young athletes.
N. // Engl J Med – 2000 – Vol. 349 –P.1064-75.97.Maron B., Bonow R.O., Salberg L. The first patient clinically diagnosed with HCM//Am. J. Cardiol. – 2008 – Vol. 102 (10) – P. 1418-20.98.Maron B.J. Sudden death in hypertrophic cardiomyopathy //J Cardiovasc TranslRes. – 2009 – № 2(4) – P.368-80.99.Maron B., Pelliccia A. The heart of trained athletes: cardiac remodeling and therisks of sports, including sudden death.
// Circulation. – 2009 – Vol.114 – №25 –P.1633-1644.100. Maron B., Doerer J., Tammy S. et al. Sudden deaths in young competitiveathletes analysis of 1866 deaths in the United States, 1980-2006 // Circulation. 2009 – Vol. 119. – P. 1085-1092.101. Millar L, Sharma S. Diagnosis and management of inherited cardiomyopathies.// Practitioner. – 2014 – № 258(1775) – Vol. 21-5 – P.2-3.102. Mir T.S., Marohn S., Plasma concentrations of N-terminal pro-brain natriureticpeptide in control children. // Pediatrics. – 2012 – №7 – P. 110.103. Moak J.P., Kaski J.P. Hypertrophic cardiomyopathy in children. // Heart. –2012 – Vol.
98(14) – P.1044-54104. Morita E., Yasue H., Yoshimura M. Increased plasma levels of brain natriureticpeptide in patients with acute myocardial infarction. // Circulation. – 2013 – Vol.88 – P. 82–91.105. Mozos I, Serban C. The relation between QT interval and T-wave variables inhypertensive patients. // J Pharm Bioallied Sci. – 2011 – №3 (3) – Р.339-44.106. Mugnai G, Benfari G.
T peak-to-T end is an independent predictor of earlyventricular arrhythmias and arrhythmic death in anterior ST elevation myocardial154infarction patients. // Eur Heart J Acute Cardiovasc Care. – 2015 – № 30 – Р. 6269.107. Nasser N., Perles Z. BNP as marker for persistent cardiac disease in childrenwith history of myocarditis. // Pediatr. Cardiol. – 2007 – Vol.27 – P.87-90.108. National High BP Education Program Working Group on High BP in Childrenand Adolescents the fourth report on the diagnosis, evaluation, and treatment ofhigh BP in Children and Adolescents.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
